Back to Results
First PageMeta Content
Respiratory therapy / Alcohols / Aging-associated diseases / Muscarinic antagonists / Propionates / Ipratropium bromide / Salbutamol / Stroke / Chronic obstructive pulmonary disease / Pulmonology / Medicine / Bronchodilators


EU PSUR Work Sharing Summary Assessment Report ® Combivent ; Combivent Respimat (Ipratropium bromide + salbutamol sulphate) HU/H/PSUR
Add to Reading List

Document Date: 2014-12-01 03:55:31

Open Document

File Size: 28,44 KB

Share Result on Facebook

Company

Boehringer Ingelheim International GmbH / the AEs / /

Country

Hungary / /

Facility

Combivent Respimat INN / /

IndustryTerm

ipratropium+salbutamol combination product / salbutamol sulphate combination products / medicinal products / /

MedicalCondition

glaucoma / arrhythmia / obstructive airway diseases / Injury / Nervous system disorders / Cardiac disorders / poisoning / reversible bronchospasm / Vascular disorders / treated underlying disease / stroke / myocardial ischemia / /

Organization

European Union / /

Product

Combivent / Ipratropium bromide / /

SocialTag